The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-M ünster Protocol With Rituximab and Consolidative Autologous Transplantation

CONCLUSION: Intensive treatment according to BFM protocol, with rituximab and ASCT, appears feasible, safe, and highly effective in adult patients with BL, as confirmed by long-term survival rates reflecting response maintenance.PMID:38339976 | DOI:10.1093/oncolo/oyae017

Source: The Oncologist - February 10, 2024 Category: Cancer & Oncology Authors: Alessandro Broccoli Lisa Argnani Gabriele Gugliotta Cinzia Pellegrini Beatrice Casadei Gianmarco Bagnato Marianna Gentilini Vittorio Stefoni Pier Luigi Zinzani Source Type: research